Centre Hospitalier Saint Joseph Saint Luc
- Address
- lock Available on a paid plan
Digestive System Diseases and Colorectal Cancer Research
At Centre Hospitalier Saint Joseph Saint Luc, clinical research in hepatogastroenterology includes studies focused on digestive system diseases, especially colon carcinoma. These trials are designed to evaluate whether new treatment strategies can improve survival and disease control for patients with locally advanced but resectable disease.
- Testing a neoadjuvant chemotherapy approach before surgery for colon cancer
- Comparing treatment pathways to see whether a pre-surgery strategy improves long-term outcomes
- Supporting more personalized care for older adults with colorectal cancer
This area of research aims to refine how colon carcinoma is managed, with a strong emphasis on treatment effectiveness and survival after surgery.
Cardiovascular Diseases and Heart Attack Prevention
The site also conducts trials in cardiovascular diseases, including acute coronary syndrome, acute myocardial infarction, and ST segment elevation myocardial infarction. These studies are exploring ways to reduce the risk of serious recurrent events after a heart attack and improve recovery for patients with recent cardiac injury.
- Evaluating a new therapy to lower the risk of major adverse cardiovascular events
- Studying treatment options after myocardial infarction to prevent future complications
- Assessing whether cardiac function can be better preserved after ST-elevation myocardial infarction
Research in this field combines prevention and recovery goals, with the aim of improving outcomes for patients at risk of further cardiovascular events.
Cardiac Recovery Imaging and Post-Heart Attack Care
Another important line of research at this hospital examines how treatments may support heart muscle recovery after acute anterior STEMI. The focus is on evaluating whether adding a targeted therapy can improve left ventricular systolic function and support better cardiac performance over time.
- Comparing a new treatment approach with placebo in patients after ST-elevation myocardial infarction
- Using cardiac magnetic resonance to assess heart function after treatment
- Exploring strategies to improve recovery of the injured myocardium
This work highlights a blend of therapeutic and diagnostic research, with the goal of better understanding and improving recovery after severe heart attack.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 11 therapeutic areas and 15 of 63 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 56 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Saint Joseph Saint Luc
lock Showing 1 of 31 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV) | Amgen Inc. | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 63 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 5 | Unknown | 2014-12-23 | 2024-06-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.